We use cookies for a better user experience. Read our Privacy Policy

I Agree

Equine Healthcare Market

Equine Healthcare Market (Product Type: Drugs, Vaccines, and Medical Supplemental Feed; Disease Type and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Equine Healthcare Market Outlook 2028

  • The global equine healthcare market was valued at US$ 698.7 Mn in 2020
  • It is estimated to expand at a CAGR of 4.3% from 2021 to 2028
  • The global equine healthcare market is expected to cross the value of US$ 972.8 Mn by the end of 2028

Analysts’ Viewpoint on Equine Healthcare Market Scenario

Equine practitioners are practicing strict biosecurity at all farms, performance venues, racetracks, and the likes during the ongoing COVID-19 pandemic. It has been found that issues of recurring common horse healthcare problems are affecting market growth. Hence, stakeholders in the equine healthcare market should increase awareness about regular de-worming schedules and professional veterinary advice to reduce the incidence of recurring common horse healthcare problems. Therapeutics such as corticosteroids are being extensively used as joint injections. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labelled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate use in horses under the age of four.

Comprehensive Equine Vaccine Portfolio Creates Revenue Opportunities for Manufacturers

Equine practitioners are performing a risk-benefit analysis to determine if a horse should receive a particular risk-based vaccine. This is necessary since extra vaccinations can be costly and can cause unnecessary stress to the horse. Manufacturers in the equine healthcare market are increasing the production of vaccines to improve clinical numbers. With the help of risk-benefit analysis, veterinarians are educating horse owners about different types of risk-based vaccines such as equine influenza and strangles vaccines for horses active at events.

Manufacturers in the equine healthcare market are developing the anthrax vaccine for horses that live in an area where spores are known to thrive in the soil. On the other hand, pregnant mares during specific months of pregnancy are advised to receive certain risk-based vaccines. Companies are developing a diverse portfolio in vaccine such as the equine herpesvirus, botulism and rotaviral diarrhea.

equine health market infographic

To know the scope of our report Get a Sample on Equine Healthcare Market

AVMA Draws Guidance for Equine Veterinarians amid Ongoing COVID-19 Pandemic

Apart from ensuring healthcare services for horses, the COVID-19 pandemic has drawn attention to the wellbeing of equine veterinarians. Stakeholders in the equine healthcare market are taking cues from the AVMA (American Veterinary Medical Association) such as following the hierarchy of controls to reduce the spread of the novel infection among equine practitioners.

While PPE (personal protective equipment) serves as an important protective function, the optimal way to prevent disease transmission is to use a combination of interventions from across the hierarchy of controls. Participants in the equine healthcare market are re-scheduling non-urgent veterinary procedures. They are considering telemedicine as an alternative to in-person visit.

Get a glimpse of the in-depth analysis through our Report Brochure

Professional Veterinary Intervention Helps Overcome Recurring Common Horse healthcare Problems

Common horse healthcare problems such as laminitis or thrush can leave a horse more likely to contract it again. Hence, participants in the market are educating horse owners to seek professional veterinary advice and veterinary intervention to improve clinical outcomes.

The high prevalence of allergies, colic, and mud fever, among other common horse healthcare problems, is triggering the demand for healthcare services. Such findings are contributing to the growth of the equine healthcare market. Problems of worms, sweet itch and back problems are translating into revenue opportunities for market stakeholders.

equine health market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Wearables Enable Early Indication of healthcare Issues in Horses

Apart from drugs, vaccines and supplemental feed additives, market stakeholders are boosting R&D in the equestrian sports technology such as wearables for horses. As such, there is a need for validated approaches of consistently and regularly tracking healthcare parameters such as temperature, heart rate, and respiratory rates. Thus, wearable devices hold promising potentials to offer these statistics.

The data gathered by wearable devices has the ability to give an earlier indication of issues, which may require veterinary investigation. Such innovations are translating into incremental opportunities for med-tech companies in the equine healthcare market.

Safety and Welfare of Horses Crucial While Innovating in Therapeutics

In the racing industry, medication use has changed drastically over the years, as manufacturers develop new drugs whilst scientists hone techniques they use to analyze and identify therapeutic medications. healthcare companies are focusing on maintaining a level playing field, protecting the safety of the horse, and protecting the betting public. As such, companies are boosting the production of corticosteroids, NSAIDs, and bisphosphonates, among other drugs.

Racing regulators have historically permitted NSAID use within 24-hrs of race time. However, in the recent times, there have been recommendations to increase the timeframe to no earlier than 48-hrs.

Equine Healthcare Market: Overview

  • According to Transparency Market Research’s latest report on the global equine healthcare market for the historical period 2017–2019 and forecast period 2021–2028, strong impact of the equine industry on the economy is projected to drive the global equine healthcare market during the forecast period

Strong Impact of Equine Industry on Economy: Key Driver

  • The equine industry involves breeding, keeping, and overall management of horses. It has a strong impact on the overall economy. The industry creates income opportunities for several veterinary physicians, equestrians, and others. Additionally, it involves a supply demand scenario of equine healthcare products. Strong economic impact of the equine industry is expected to drive the global equine healthcare market.

High Incidence of Equine Infections: Major Driver

  • Horse breeding is a core activity in the equine industry. Hence, choice of breeding stock and better healthcare management of breeds are crucial to improve breeding operations. Occurrence of equine infections is another major concern for the breeders. For instance, South America and the Caribbean have high incidence of Potomac horse fever.
  • The West Nile Virus infection among horses has been controlled; however, sudden emergence of the virus can cause concerns among horse owners. Moreover, tetanus and equine influenza cases are evident among the global horse community. Hence, high incidence of equine infections is likely to drive the global equine healthcare market.

Decline in Global Equine Population to Hamper Market

  • The global equine healthcare market has strong correlation with the global equine population
  • According to a research, the horse population in the Americas declined by 5.37% in the past five years, while the horse population declined by 7.47% during the same period
  • Hence, fall in the global horse population is likely to restrain the global equine healthcare market during the forecast period

Equine Healthcare Market: Competition Landscape

  • This report profiles major players in the global equine healthcare market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global equine healthcare market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global equine healthcare market are
    • Bayer AG (Bayer Animal healthcare)
    • Boehringer Ingelheim
    • Ceva Santé Animale
    • Eli Lilly and Company (Elanco)
    • Equine Products UK Ltd.
    • Merck & Co. (Merck Animal healthcare)
    • Sanofi (Merial)
    • Purina Animal Nutrition LLC.
    • Vetoquinol S.A.
    • Zoetis

Equine Healthcare Market: Key Developments

  • Key players in the global equine healthcare market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global equine healthcare market. A few expansion strategies adopted by players operating in the global equine healthcare market are:
    • Merck & Co. (Merck Animal healthcare) is committed to bringing the latest technologies to the research efforts. The company focuses on advancing veterinary medicine through novel solutions in key therapeutic areas. Acquisition of Vallée S.A would make Merck & Co. a renowned player in Brazil, and thereby in Latin America in the near future. Merck & Co. is likely to gain market share in Latin America during the forecast period.
    • Bayer Animal healthcare is a global leader in animal healthcare and helps farmers, veterinarians, and pet owners by offering innovative products. The company develops and commercializes vaccines, drugs, and other products for companion and farm animals. The products reduce the risk of transmission of pathogens from animals to humans. It has expanded business globally and has strong presence in North America and Europe. Its primary manufacturing units are in Germany and the U.S.
  • The report on the global equine healthcare market discusses individual strategies, followed by company profiles of manufacturers of equine healthcare products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global equine healthcare market.

Equine Healthcare Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 698.7 Mn

Market Forecast Value in 2028

US$ 972.8 Mn

Growth Rate (CAGR)

4.3%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Products Type
    • Drugs
      • Anti-infectives
      • Anti-inflammatory
      • Parasiticides
      • Others
    • Vaccine
      • Inactivated
      • Live Attenuated
      • Recombinant
      • Others
    • Supplemental Feed additives
      • Proteins & Amino Acids
      • Vitamins
      • Enzymes
      • Minerals
      • Others
  • Distribution Channel
    • Veterinary Hospitals & Clinics
    • Pharmacies & Drug Stores
    • Others
  • Disease Type
    • Equine Influenza
    • Rhinopneumonitis/Equine Herpes Virus (EHV)
    • Equine Encephalomyelitis (sleeping sickness)
    • Equine Infectious Anemia (EIA)
    • West Nile Virus
    • Equine Rabies
    • Potomac Horse Fever
    • Tetanus (Lockjaw)
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Equine Healthcare Market – Segmentation

Product Type
  • Drugs
    • Anti-infectives
    • Anti-inflammatory
    • Parasititidis
    • Others
  • Vaccines
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed additives
    • Proteins & Amino Acids
    • Vitamins
    • Enzymes
    • Minerals
    • Others
Disease Type
  • Equine Influenza
  • Rhinopneumonitis/Equine Herpes Virus (EHV)
  • Equine Encephalomyelitis (Sleeping Sickness)
  • Equine Infectious Anemia (EIA)
  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus (Lockjaw)
  • Others
Distribution Channel
  • Veterinary Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Equine Healthcare Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of equine healthcare market?

The global equine healthcare market was worth US$601.7 mn and is projected to reach a value of US$ 862.7 mn by the end of 2025

What is the anticipated CAGR of the equine healthcare market in the forecast period?

Equine healthcare market is anticipated to grow at a CAGR of 4.2% during the forecast period

Which region is expected to project the highest market share in the global equine healthcare market?

North america accounted for a major share of the global equine healthcare market

What are the key driving factors for the growth of the equine healthcare market?

The key factors driving equine healthcare market expansion include increased trend of horseracing and noteworthy growth in spending toward activities pertaining to equine care across the major parts of the globe

Who are the key players in the global equine healthcare market?

Key players in the global equine healthcare market include Sanofi (Merial), Zoetis, Vetoquinol S.A., Purina Animal Nutrition LLC., and Bayer AG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Equine Healthcare Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

    5.1. Coagulation Disorders & Coagulation Pathways: Overview

    5.2. Epidemiology: Coagulation Disorders

    5.3. Regulatory Framework

    5.4. Reimbursement Scenario

    5.5. Equine Healthcare Market: Pricing Analysis

    5.6. Equine Healthcare Market: Value Chain Analysis

    5.7. Equine Healthcare Market: Porter’s Five Forces Analysis

6. Global Equine Healthcare Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017–2028

        6.2.1. Drugs

            6.2.1.1. Anti-infectives

            6.2.1.2. Anti-inflammatory

            6.2.1.3. Parasiticides

            6.2.1.4. Others

        6.2.2. Vaccines

            6.2.2.1. Inactivated

            6.2.2.2. Live Attenuated

            6.2.2.3. Recombinant

            6.2.2.4. Others

        6.2.3. Medical Supplemental Feed

            6.2.3.1. Minerals

            6.2.3.2. Vitamins

            6.2.3.3. Protein

            6.2.3.4. Enzyme

            6.2.3.5. Others

    6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type

7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017–2028

        7.2.1. West Nile Virus

        7.2.2. Equine Rabies

        7.2.3. Potomac Horse Fever

        7.2.4. Tetanus

        7.2.5. Equine Influenza

        7.2.6. Equine Herpes Virus

        7.2.7. Equine Encephalomyelitis

        7.2.8. Others (equine infectious anemia)

    7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type

8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017–2028

        8.2.1. Veterinary Hospitals & Clinics

        8.2.2. Retail Pharmacies & Drug Stores

        8.2.3. Others

9. Global Equine Healthcare Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Equine Healthcare Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region

10. North America Equine Healthcare Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

        10.2.1. Drugs

            10.2.1.1. Anti-infectives

            10.2.1.2. Anti-infectives

            10.2.1.3. Anti-inflammatory

            10.2.1.4. Parasiticides

            10.2.1.5. Others

            10.2.1.6. Transfer Lifts

            10.2.1.7. Door Openers

            10.2.1.8. Others

        10.2.2. Vaccines

            10.2.2.1. Inactivated

            10.2.2.2. Live Attenuated

            10.2.2.3. Recombinant

            10.2.2.4. Others

            10.2.2.5. Others

        10.2.3. Medical Supplemental Feed

            10.2.3.1. Minerals

            10.2.3.2. Vitamins

            10.2.3.3. Protein

            10.2.3.4. Enzyme

            10.2.3.5. Others

    10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

        10.3.1. West Nile Virus

        10.3.2. Equine Rabies

        10.3.3. Potomac Horse Fever

        10.3.4. Tetanus

        10.3.5. Equine Influenza

        10.3.6. Equine Herpes Virus

        10.3.7. Equine Encephalomyelitis

        10.3.8. Others (equine infectious anemia)

    10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        10.4.1. Veterinary Hospitals & Clinics

        10.4.2. Retail Pharmacies & Drug Stores

        10.4.3. Others

    10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Equine Healthcare Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Disease Type

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

        11.2.1. Drugs

            11.2.1.1. Anti-infectives

            11.2.1.2. Anti-infectives

            11.2.1.3. Anti-inflammatory

            11.2.1.4. Parasiticides

            11.2.1.5. Others

            11.2.1.6. Transfer Lifts

            11.2.1.7. Door Openers

            11.2.1.8. Others

        11.2.2. Vaccines

            11.2.2.1. Inactivated

            11.2.2.2. Live Attenuated

            11.2.2.3. Recombinant

            11.2.2.4. Others

            11.2.2.5. Others

        11.2.3. Medical Supplemental Feed

            11.2.3.1. Minerals

            11.2.3.2. Vitamins

            11.2.3.3. Protein

            11.2.3.4. Enzyme

            11.2.3.5. Others

    11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

        11.3.1. West Nile Virus

        11.3.2. Equine Rabies

        11.3.3. Potomac Horse Fever

        11.3.4. Tetanus

        11.3.5. Equine Influenza

        11.3.6. Equine Herpes Virus

        11.3.7. Equine Encephalomyelitis

        11.3.8. Others (Equine Infectious Anemia)

    11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        11.4.1. Veterinary Hospitals & Clinics

        11.4.2. Retail Pharmacies & Drug Stores

        11.4.3. Others

    11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Equine Healthcare Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Disease Type

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

        12.2.1. Drugs

            12.2.1.1. Anti-infectives

            12.2.1.2. Anti-infectives

            12.2.1.3. Anti-inflammatory

            12.2.1.4. Parasiticides

            12.2.1.5. Others

            12.2.1.6. Transfer Lifts

            12.2.1.7. Door Openers

            12.2.1.8. Others

        12.2.2. Vaccines

            12.2.2.1. Inactivated

            12.2.2.2. Live Attenuated

            12.2.2.3. Recombinant

            12.2.2.4. Others

            12.2.2.5. Others

        12.2.3. Medical Supplemental Feed

            12.2.3.1. Minerals

            12.2.3.2. Vitamins

            12.2.3.3. Protein

            12.2.3.4. Enzyme

            12.2.3.5. Others

    12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

        12.3.1. West Nile Virus

        12.3.2. Equine Rabies

        12.3.3. Potomac Horse Fever

        12.3.4. Tetanus

        12.3.5. Equine Influenza

        12.3.6. Equine Herpes Virus

        12.3.7. Equine Encephalomyelitis

        12.3.8. Others (equine infectious anemia)

    12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        12.4.1. Veterinary Hospitals & Clinics

        12.4.2. Retail Pharmacies & Drug Stores

        12.4.3. Others

    12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Disease Type

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

        13.2.1. Drugs

            13.2.1.1. Anti-infectives

            13.2.1.2. Anti-infectives

            13.2.1.3. Anti-inflammatory

            13.2.1.4. Parasiticides

            13.2.1.5. Others

            13.2.1.6. Transfer Lifts

            13.2.1.7. Door Openers

            13.2.1.8. Others

        13.2.2. Vaccines

            13.2.2.1. Inactivated

            13.2.2.2. Live Attenuated

            13.2.2.3. Recombinant

            13.2.2.4. Others

            13.2.2.5. Others

        13.2.3. Medical Supplemental Feed

            13.2.3.1. Minerals

            13.2.3.2. Vitamins

            13.2.3.3. Protein

            13.2.3.4. Enzyme

            13.2.3.5. Others

    13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

        13.3.1. West Nile Virus

        13.3.2. Equine Rabies

        13.3.3. Potomac Horse Fever

        13.3.4. Tetanus

        13.3.5. Equine Influenza

        13.3.6. Equine Herpes Virus

        13.3.7. Equine Encephalomyelitis

        13.3.8. Others (equine infectious anemia)

    13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        13.4.1. Veterinary Hospitals & Clinics

        13.4.2. Retail Pharmacies & Drug Stores

        13.4.3. Others

    13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America Latin America

    13.6. Latin America Equine Healthcare Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Disease Type

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

        14.2.1. Drugs

            14.2.1.1. Anti-infectives

            14.2.1.2. Anti-infectives

            14.2.1.3. Anti-inflammatory

            14.2.1.4. Parasiticides

            14.2.1.5. Others

            14.2.1.6. Transfer Lifts

            14.2.1.7. Door Openers

            14.2.1.8. Others

        14.2.2. Vaccines

            14.2.2.1. Inactivated

            14.2.2.2. Live Attenuated

            14.2.2.3. Recombinant

            14.2.2.4. Others

            14.2.2.5. Others

        14.2.3. Medical Supplemental Feed

            14.2.3.1. Minerals

            14.2.3.2. Vitamins

            14.2.3.3. Protein

            14.2.3.4. Enzyme

            14.2.3.5. Others

    14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

        14.3.1. West Nile Virus

        14.3.2. Equine Rabies

        14.3.3. Potomac Horse Fever

        14.3.4. Tetanus

        14.3.5. Equine Influenza

        14.3.6. Equine Herpes Virus

        14.3.7. Equine Encephalomyelitis

        14.3.8. Others (equine infectious anemia)

    14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

        14.4.1. Veterinary Hospitals & Clinics

        14.4.2. Retail Pharmacies & Drug Stores

        14.4.3. Others

    14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Disease Type

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share / Position Analysis, by Company, 2020

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. Bayer AG (Bayer Animal Healthcare)

            15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.1.2. Financial Analysis

            15.4.1.3. Growth Strategies

            15.4.1.4. SWOT Analysis

        15.4.2. Boehringer Ingelheim

            15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.2.2. Financial Analysis

            15.4.2.3. Growth Strategies

            15.4.2.4. SWOT Analysis

        15.4.3. Ceva Santé Animale

            15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.3.2. Financial Analysis

            15.4.3.3. Growth Strategies

            15.4.3.4. SWOT Analysis

        15.4.4. Eli Lilly and Company (Elanco)

            15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.4.2. Financial Analysis

            15.4.4.3. Growth Strategies

            15.4.4.4. SWOT Analysis

        15.4.5. Equine Products U.K. Ltd.

            15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.5.2. Financial Analysis

            15.4.5.3. Growth Strategies

            15.4.5.4. SWOT Analysis

        15.4.6. Merck & Co. (Merck Animal Healthcare)

            15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.6.2. Financial Analysis

            15.4.6.3. Growth Strategies

            15.4.6.4. SWOT Analysis

        15.4.7. Sanofi (Merial)

            15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.7.2. Financial Analysis

            15.4.7.3. Growth Strategies

            15.4.7.4. SWOT Analysis

        15.4.8. Purina Animal Nutrition LLC

            15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.8.2. Financial Analysis

            15.4.8.3. Growth Strategies

            15.4.8.4. SWOT Analysis

        15.4.9. Vetoquinol S.A.

            15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.9.2. Financial Analysis

            15.4.9.3. Growth Strategies

            15.4.9.4. SWOT Analysis

        15.4.10. Zoetis

            15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.10.2. Financial Analysis

            15.4.10.3. Growth Strategies

            15.4.10.4. SWOT Analysis

List of Table

Table 01: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2021–2028

Table 05: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 06: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 07: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 08: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Country, 2021–2028

Table 09: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 10: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 11: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 12: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

Table 13: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 14: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 15: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 16: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

Table 17: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 18: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 19: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 20: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

Table 21: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

Table 22: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

Table 23: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

Table 24: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

List of Figure

Figure 01: Equine Healthcare Market Snapshot

Figure 02: Global Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2028

Figure 03: Market Value Share, by Product, 2020

Figure 04: Market Value Share, by Disease Type, 2020

Figure 05: Market Value Share, by Distribution Channel, 2020

Figure 06: Market Value Share, by Region, 2020

Figure 07: Global Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 08: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2028

Figure 09: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2028

Figure 10: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Supplemental Feed, 2017–2028

Figure 11: Global Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 12: Global Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 13: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by West Nile Virus, 2017–2028

Figure 14: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EQUINE RABIES, 2017–2028

Figure 15: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Potomac Horse Fever, 2017–2028

Figure 16: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetanus, 2017–2028

Figure 17: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Influenza, 2017–2028

Figure 18: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Herpes Virus, 2017–2028

Figure 19: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Encephalomyelitis, 2017–2028

Figure 20: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Equine Infectious Anemia), 2017–2028

Figure 21: Global Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 22: Global Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 23: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals & Clinics, 2017–2028

Figure 24: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies & Drug Stores, 2017–2028

Figure 25: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028

Figure 26: Global Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 27: Global Equine Healthcare Market Value Share Analysis, by Region, 2020 and 2028

Figure 28: Global Equine Healthcare Market Attractiveness Analysis, by Region, 2021–2028

Figure 29: North America Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028

Figure 30: North America Equine Healthcare Market Attractiveness Analysis, by Country, 2021–2028

Figure 31: North America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 32: North America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 33: North America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 34: North America Equine Healthcare Market Value Share Analysis, by Country, 2020 and 2028

Figure 35: North America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 36: North America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 37: North America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 38: Europe Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028

Figure 39: Europe Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 40: Europe Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 41: Europe Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 42: Europe Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 43: Europe Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 44: Europe Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 45: Europe Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 46: Europe Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 47: Asia Pacific Equine Healthcare Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017– 2028

Figure 48: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 49: Asia Pacific Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 50: Asia Pacific Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 51: Asia Pacific Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 52: Asia Pacific Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 53: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 54: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 55: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 56: Latin America Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 57: Latin America Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 58: Latin America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 59: Latin America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 60: Latin America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 61: Latin America Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 62: Latin America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 63: Latin America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 64: Latin America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 65: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, 2017–2028

Figure 66: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 67: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

Figure 68: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

Figure 69: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

Figure 70: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 71: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

Figure 72: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

Figure 73: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

Figure 74: Global Equine Healthcare Market Share Analysis, by Company, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

628

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved